Top

Published in:

01-03-2013 | Original

Early acid–base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis

Authors: Rinaldo Bellomo, Miklos Lipcsey, Paolo Calzavacca, Michael Haase, Anjia Haase-Fielitz, Elisa Licari, Augustine Tee, Louise Cole, Alan Cass, Simon Finfer, Martin Gallagher, Joanne Lee, Serigne Lo, Colin McArthur, Shay McGuinness, John Myburgh, Carlos Scheinkestel, The RENAL Study Investigators and The ANZICS Clinical Trials Group

Published in: Intensive Care Medicine | Issue 3/2013

Abstract

Purpose

In acute kidney injury patients, metabolic acidosis is common. Its severity, duration, and associated changes in mean arterial pressure (MAP) and vasopressor therapy may be affected by the intensity of continuous renal replacement therapy (CRRT). We aimed to compare key aspects of acidosis and MAP and vasopressor therapy in patients treated with two different CRRT intensities.

Methods

We studied a nested cohort of 115 patients from two tertiary intensive care units (ICUs) within a large multicenter randomized controlled trial treated with lower intensity (LI) or higher intensity (HI) CRRT.

Results

Levels of metabolic acidosis at randomization were similar [base excess (BE) of −8 ± 8 vs. −8 ± 7 mEq/l; p = 0.76]. Speed of BE correction did not differ between the two groups. However, the HI group had a greater increase in MAP from baseline to 24 h (7 ± 3 vs. 0 ± 3 mmHg; p < 0.01) and a greater decrease in norepinephrine dose (from 12.5 to 3.5 vs. 5 to 2.5 μg/min; p < 0.05). The correlation (r) coefficients between absolute change in MAP and norepinephrine (NE) dose versus change in BE were 0.05 and −0.37, respectively.

Conclusions

Overall, LI and HI CRRT have similar acid–base effects in patients with acidosis. However, HI was associated with greater improvements in MAP and vasopressor requirements (clinical trial no. NCT00221013).

Available only for authorised users

Tresguerres M, Buck J, Levin LR (2010) Physiological carbon dioxide, bicarbonate, and pH sensing. Pflugers Arch 460:953–964PubMedCrossRef

Adrogue HE, Adrogue HJ (2001) Acid-base physiology. Respir Care 46:328–341PubMed

Gunnerson KJ (2005) Clinical review: the meaning of acid-base abnormalities in the intensive care unit part I—epidemiology. Crit Care 9:508–516PubMedCrossRef

Bailey JL, Mitch WE (1998) The implications of metabolic acidosis in intensive care unit patients. Nephrol Dial Transplant 13:837–839PubMedCrossRef

Lee SW, Hong YS, Park DW, Choi SH, Moon SW, Park JS, Kim JY, Baek KJ (2008) Lactic acidosis not hyperlactatemia as a predictor of in hospital mortality in septic emergency patients. Emerg Med J 25:659–665PubMedCrossRef

Clermont G, Acker CG, Angus DC, Sirio CA, Pinsky MR, Johnson JP (2002) Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 62:986–996PubMedCrossRef

Guth HJ, Zschiesche M, Panzig E, Rudolph PE, Jager B, Kraatz G (1999) Which organic acids does hemofiltrate contain in the presence of acute renal failure? Int J Artif Organs 22:805–810PubMed

Naka T, Bellomo R (2004) Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit–the role of renal replacement therapy. Crit Care 8:108–114PubMedCrossRef

Feriani M, Dell’Aquila R (1998) Acid-base balance and replacement solutions in continuous renal replacement therapies. Kidney Int Suppl 66:S156–S159PubMed

10.

Nimmo GR, Mackenzie SJ, Walker S, Nicol M, Grant IS (1993) Acid-base responses to high-volume haemofiltration in the critically ill. Nephrol Dial Transplant 8:854–857PubMed

11.

Hilton PJ, Taylor J, Forni LG, Treacher DF (1998) Bicarbonate-based haemofiltration in the management of acute renal failure with lactic acidosis. QJM 91:279–283PubMedCrossRef

12.

Davenport A, Will EJ, Davison AM (1989) The effect of lactate-buffered solutions on the acid-base status of patients with renal failure. Nephrol Dial Transplant 4:800–804PubMed

13.

Locatelli F, Pontoriero G, Di Filippo S (1998) Electrolyte disorders and substitution fluid in continuous renal replacement therapy. Kidney Int Suppl 66:S151–S155PubMed

14.

Evanson JA, Himmelfarb J, Wingard R, Knights S, Shyr Y, Schulman G, Ikizler TA, Hakim RM (1998) Prescribed versus delivered dialysis in acute renal failure patients. Am J Kidney Dis 32:731–738PubMedCrossRef

15.

Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627–1638PubMedCrossRef

16.

Kellum JA, Kramer DJ, Pinsky MR (1995) Strong ion gap: a methodology for exploring unexplained anions. J Crit Care 10:51–55PubMedCrossRef

17.

Figge J, Mydosh T, Fencl V (1992) Serum proteins and acid-base equilibria: a follow-up. J Lab Clin Med 120:713–719PubMed

18.

Stewart PA (1983) Modern quantitative acid-base chemistry. Can J Physiol Pharmacol 61:1444–1461PubMedCrossRef

19.

Demirjian S, Teo BW, Paganini EP (2008) Alkalemia during continuous renal replacement therapy and mortality in critically ill patients. Crit Care Med 36:1513–1517PubMedCrossRef

20.

Rocktaschel J, Morimatsu H, Uchino S, Ronco C, Bellomo R (2003) Impact of continuous veno-venous hemofiltration on acid-base balance. Int J Artif Organs 26:19–25PubMed

21.

Burnell JM, Scribner BH, Uyeno BT, Villamil MF (1956) The effect in humans of extracellular pH change on the relationship between serum potassium concentration and intracellular potassium. J Clin Invest 35:935–939PubMedCrossRef

22.

Bellomo R, Kellum JA, Gandhi CR, Pinsky MR, Ondulik B (2000) The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 161:1429–1436PubMed

23.

Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P (2001) High-volume haemofiltration in human septic shock. Intensive Care Med 27:978–986PubMedCrossRef

24.

Klouche K, Cavadore P, Portales P, Clot J, Canaud B, Beraud JJ (2002) Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations. J Nephrol 15:150–157PubMed

25.

Ratanarat R, Brendolan A, Piccinni P, Dan M, Salvatori G, Ricci Z, Ronco C (2005) Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 9:R294–R302PubMedCrossRef

26.

Boussekey N, Chiche A, Faure K, Devos P, Guery B, d’Escrivan T, Georges H, Leroy O (2008) A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med 34:1646–1653PubMedCrossRef

27.

Huang YG, Wong KC, Yip WH, McJames SW, Pace NL (1995) Cardiovascular responses to graded doses of three catecholamines during lactic and hydrochloric acidosis in dogs. Br J Anaesth 74:583–590PubMedCrossRef

28.

Schulte-Sasse U, Hess W, Schweichel E, Tarnow J, Bruckner JB (1981) Systemic and coronary haemodynamic effects of dobutamine and norepinephrine during metabolic acidosis. Anaesthesist 30:455–460PubMed

29.

Peng Z, Pai P, Hong-Bao L, Rong L, Han-Min W, Chen H (2010) The impacts of continuous veno-venous hemofiltration on plasma cytokines and monocyte human leukocyte antigen-DR expression in septic patients. Cytokine 50:186–191PubMedCrossRef

30.

Haase M, Silvester W, Uchino S, Goldsmith D, Davenport P, Tipping P, Boyce N, Bellomo R (2007) A pilot study of high-adsorption hemofiltration in human septic shock. Int J Artif Organs 30:108–117PubMed

31.

Ghani RA, Zainudin S, Ctkong N, Rahman AF, Wafa SR, Mohamad M, Manaf MR, Ismail R (2006) Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous veno-venous haemofiltration. Nephrology (Carlton) 11:386–393CrossRef

32.

Biesheuvel CJ, Vergouwe Y, Oudega R, Hoes AW, Grobbee DE, Moons KG (2008) Advantages of the nested case-control design in diagnostic research. BMC Med Res Methodol 8:48PubMedCrossRef

33.

Vesconi S, Cruz DN, Fumagalli R, Kindgen-Milles D, Monti G, Marinho A, Mariano F, Formica M, Marchesi M, Rene R, Livigni S, Ronco C (2009) Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 13:R57PubMedCrossRef

34.

Morris CG, Low J (2008) Metabolic acidosis in the critically ill: part 2. Causes and treatment. Anaesthesia 63:396–411PubMedCrossRef

35.

Oudemans-van Straaten HM, Kellum JA, Bellomo R (2011) Clinical review: anticoagulation for continuous renal replacement therapy—heparin or citrate? Crit Care 15:202PubMedCrossRef

Title: Early acid–base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis
Authors: Rinaldo Bellomo
Miklos Lipcsey
Paolo Calzavacca
Michael Haase
Anjia Haase-Fielitz
Elisa Licari
Augustine Tee
Louise Cole
Alan Cass
Simon Finfer
Martin Gallagher
Joanne Lee
Serigne Lo
Colin McArthur
Shay McGuinness
John Myburgh
Carlos Scheinkestel
The RENAL Study Investigators and The ANZICS Clinical Trials Group
Publication date: 01-03-2013
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 3/2013
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-012-2800-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Early acid–base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2013

Acute respiratory distress syndrome secondary to human metapneumovirus infection in a young healthy adult

Increased long-term mortality with plasma transfusion after coronary artery bypass surgery

For control of colonisation with extended-spectrum β-lactamase-producing bacteria, SDD does work

Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit?

Intensive care unit environment may affect the course of delirium

Anthrax infection in an intravenous drug user